EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.

Item

http://www.wikidata.org/entity/Q38391135

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.

@en

type

Item

label

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.

@en

prefLabel

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.

@en

P1476

EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.

@en

P2093

Ahmet Bircan

http://www.w3.org/2001/XMLSchema#string

Huseyin Baloglu

http://www.w3.org/2001/XMLSchema#string

Sema Bircan

http://www.w3.org/2001/XMLSchema#string

Zafer Kucukodaci

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

KRAS mutations in non-small cell lung cancer

Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation

Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients.

Impact of EGFR inhibitor in non-small cell lung cancer on progression-free and overall survival: a meta-analysis.

Impact of EGFR mutation analysis in non-small cell lung cancer.

P2888

s12032-014-0087-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0087-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1029766450

http://www.w3.org/2001/XMLSchema#string

P698

24973952

http://www.w3.org/2001/XMLSchema#string